Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Genetics and the common cancers.

J Peto1, R S Houlston

  • 1Section of Epidemiology, Institute of Cancer Research, Sutton, Surrey SM2 5NG, UK. j.peto@icr.ac.uk

European Journal of Cancer (Oxford, England : 1990)
|October 17, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Analysis of rare disruptive germline mutations in 2135 enriched BRCA-negative breast cancers excludes additional high-impact susceptibility genes.

Annals of oncology : official journal of the European Society for Medical Oncology·2022
Same author

Triaging women with human papillomavirus infection and normal cytology or low-grade dyskaryosis: evidence from 10-year follow up of the ARTISTIC trial cohort.

BJOG : an international journal of obstetrics and gynaecology·2019
Same author

Correction: Whole-genome sequencing of chronic lymphocytic leukaemia reveals distinct differences in the mutational landscape between IgHV<sup>mut</sup> and IgHV<sup>unmut</sup> subgroups.

Leukemia·2019
Same author

Runs of homozygosity and testicular cancer risk.

Andrology·2019
Same author

Whole-genome sequencing of chronic lymphocytic leukaemia reveals distinct differences in the mutational landscape between IgHV<sup>mut</sup> and IgHV<sup>unmut</sup> subgroups.

Leukemia·2017
Same author

Mendelian randomisation analysis provides no evidence for a relationship between adult height and testicular cancer risk.

Andrology·2017

Most common cancers are not explained by rare, high-penetrance genes. Instead, a susceptible minority carrying low-penetrance genes likely accounts for significant familial cancer risk, warranting further research into gene identification.

Area of Science:

  • Genetics
  • Cancer Epidemiology
  • Bioinformatics

Background:

  • Familial cancer risk is not fully explained by rare, highly penetrant genes.
  • A growing body of evidence suggests a subset of the population with specific gene combinations contributes significantly to cancer susceptibility.

Purpose of the Study:

  • To review the evidence supporting the existence of low-penetrance genes contributing to common cancer risk.
  • To discuss the potential for identifying these low-penetrance genes and gene combinations.

Main Methods:

  • Literature review of genetic studies on familial cancer risk.
  • Analysis of evidence for gene-gene and gene-environment interactions in cancer predisposition.
  • Discussion of current and future strategies for identifying low-penetrance susceptibility genes.

Related Experiment Videos

Main Results:

  • Rare, high-penetrance genes explain only a small fraction of familial cancer risk.
  • Evidence indicates that low-penetrance genes or their combinations are likely responsible for the susceptibility in a minority of individuals.
  • Identifying these genes presents a significant challenge but is crucial for understanding cancer etiology.

Conclusions:

  • Low-penetrance genes are likely key contributors to familial cancer risk in a susceptible population subset.
  • Further research and advanced methodologies are needed to identify these genetic factors.
  • Understanding these genetic underpinnings could lead to improved cancer risk assessment and prevention strategies.